Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Oncology

Background:

• Peptidyl-prolyl cis/trans isomerase Pin1 is crucial in oncogenic signaling pathways.
• Pin1 inhibition offers a strategy to disrupt these pathways and induce cancer cell apoptosis.

Purpose of the Study:

• To design and synthesize novel benzimidazole derivatives as potential Pin1 inhibitors.
• To evaluate the inhibitory potency and antiproliferative activity of these compounds.

Main Methods:

• Chemical synthesis of a series of benzimidazole derivatives.
• In vitro assays to determine Pin1 inhibitory activity (IC50 values).
• In vitro antiproliferative assays against human prostate cancer PC-3 cells.

Main Results:

• Compounds 6h and 13g exhibited potent Pin1 inhibition with IC50 values of 0.64 μM and 0.37 μM, respectively.
• Several derivatives (6d, 6g, 6h, 6n, 6o, 7c) showed moderate antiproliferative activity against PC-3 cells.
• The synthesized benzimidazole derivatives show promise as effective Pin1 inhibitors.

Conclusions:

• Novel benzimidazole derivatives effectively inhibit Pin1.
• These compounds possess antiproliferative properties against prostate cancer cells.
• Further exploration of these derivatives as Pin1 inhibitors is warranted.